Wave Life Sciences Ownership 2024 | Who Owns Wave Life Sciences Now?
Institutional Ownership
86.16%
Insider Ownership
16.53%
Retail Ownership
-2.69%
Institutional Holders
133.00
Wave Life Sciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 17.16% | 0.16% | 18,202,009 | - | - | 112,306,396 | Mar 31, 2024 |
| MAVERICK CAPITAL LTD | 7.25% | 0.89% | 7,688,079 | -759,725 | -8.99% | 47,435,447 | Mar 31, 2024 |
| M28 CAPITAL MANAGEMENT LP | 6.60% | 31.91% | 7,000,000 | -373,413 | -5.06% | 43,190,000 | Mar 31, 2024 |
| BLACKROCK INC. | 6.01% | 0.00% | 6,375,250 | 1,008,962 | 18.80% | 39,335,294 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 5.04% | 2.42% | 5,350,000 | -250,000 | -4.46% | 33,009,500 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.90% | 0.06% | 5,201,389 | -786,341 | -13.13% | 32,092,570 | Mar 31, 2024 |
| BELLEVUE GROUP AG | 3.86% | 0.39% | 4,094,458 | -400,000 | -8.90% | 25,262,806 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 3.82% | 0.64% | 4,051,400 | 1,044,000 | 34.71% | 24,997,138 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.71% | 2.54% | 3,932,082 | - | - | 24,260,946 | Mar 31, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 2.71% | 0.01% | 2,876,440 | -882,968 | -23.49% | 17,747,635 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.86% | 0.03% | 1,974,737 | -1,238,763 | -38.55% | 12,184,127 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.80% | 0.00% | 1,912,742 | 452,978 | 31.03% | 11,802,961 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.75% | 0.00% | 1,861,254 | 233,891 | 14.37% | 11,485,000 | Mar 31, 2024 |
| VANGUARD GROUP INC | 1.73% | 0.00% | 1,834,090 | 521,665 | 39.75% | 11,316,335 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.54% | 0.00% | 1,635,610 | 1,121,029 | 217.85% | 10,091,714 | Mar 31, 2024 |
| STATE STREET CORP | 1.43% | 0.00% | 1,514,419 | 250,690 | 19.84% | 9,343,965 | Mar 31, 2024 |
| FMR LLC | 1.10% | 0.00% | 1,168,773 | -33,442 | -2.78% | 7,211,329 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.89% | 0.05% | 948,444 | -443,117 | -31.84% | 5,851,899 | Mar 31, 2024 |
| MORGAN STANLEY | 0.89% | 0.00% | 945,120 | 754,792 | 396.57% | 5,831,390 | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.82% | 0.05% | 871,500 | -200,000 | -18.67% | 5,377,155 | Mar 31, 2024 |
Wave Life Sciences's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 17.16% of the company's total share outstanding, currently valued at $112.31M. The top 10 institutional shareholders own together 61.05% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M28 CAPITAL MANAGEMENT LP | 6.60% | 31.91% | 7,000,000 | -373,413 | -5.06% | 43,190,000 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.71% | 2.54% | 3,932,082 | - | - | 24,260,946 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 5.04% | 2.42% | 5,350,000 | -250,000 | -4.46% | 33,009,500 | Mar 31, 2024 |
| MAVERICK CAPITAL LTD | 7.25% | 0.89% | 7,688,079 | -759,725 | -8.99% | 47,435,447 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.47% | 0.85% | 495,471 | 495,471 | 100.00% | 3,057,056 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 3.82% | 0.64% | 4,051,400 | 1,044,000 | 34.71% | 24,997,138 | Mar 31, 2024 |
| NEWTYN MANAGEMENT, LLC | 0.47% | 0.61% | 500,000 | -10,000 | -1.96% | 3,085,000 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.56% | 0.40% | 590,088 | 590,088 | 100.00% | 3,640,843 | Mar 31, 2024 |
| BELLEVUE GROUP AG | 3.86% | 0.39% | 4,094,458 | -400,000 | -8.90% | 25,262,806 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.27% | 0.22% | 286,585 | 286,585 | 100.00% | 1,768,229 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.04% | 0.20% | 40,000 | - | - | 246,800 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 17.16% | 0.16% | 18,202,009 | - | - | 112,306,396 | Mar 31, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.57% | 0.15% | 600,155 | -55,176 | -8.42% | 3,702,956 | Mar 31, 2024 |
| KRAEMATON INVESTMENT ADVISORS, INC | 0.02% | 0.14% | 22,000 | -25,000 | -53.19% | 135,740 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.90% | 0.06% | 5,201,389 | -786,341 | -13.13% | 32,092,570 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.89% | 0.05% | 948,444 | -443,117 | -31.84% | 5,851,899 | Mar 31, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.05% | 0.05% | 56,051 | 56,051 | 100.00% | 345,835 | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.14% | 0.05% | 144,300 | 144,300 | 100.00% | 890,331 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.09% | 0.05% | 95,037 | 95,037 | 100.00% | 586,000 | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.82% | 0.05% | 871,500 | -200,000 | -18.67% | 5,377,155 | Mar 31, 2024 |
The largest Wave Life Sciences shareholder by % of total assets is M28 CAPITAL MANAGEMENT LP. The company owns 7.00M shares of Wave Life Sciences (WVE), representing 31.91% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1.54% | 0.00% | 1,635,610 | 1,121,029 | 217.85% | 10,091,714 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 3.82% | 0.64% | 4,051,400 | 1,044,000 | 34.71% | 24,997,138 | Mar 31, 2024 |
| BLACKROCK INC. | 6.01% | 0.00% | 6,375,250 | 1,008,962 | 18.80% | 39,335,294 | Mar 31, 2024 |
| MORGAN STANLEY | 0.89% | 0.00% | 945,120 | 754,792 | 396.57% | 5,831,390 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.56% | 0.40% | 590,088 | 590,088 | 100.00% | 3,640,843 | Mar 31, 2024 |
| VANGUARD GROUP INC | 1.73% | 0.00% | 1,834,090 | 521,665 | 39.75% | 11,316,335 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.47% | 0.85% | 495,471 | 495,471 | 100.00% | 3,057,056 | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.44% | 0.01% | 462,582 | 462,582 | 100.00% | 2,854,131 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.80% | 0.00% | 1,912,742 | 452,978 | 31.03% | 11,802,961 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.39% | 0.01% | 416,725 | 390,182 | 1470.00% | 2,571,193 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.32% | 0.00% | 336,589 | 324,689 | 2728.48% | 2,076,754 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.27% | 0.22% | 286,585 | 286,585 | 100.00% | 1,768,229 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.27% | 0.00% | 285,092 | 285,092 | 100.00% | 1,759,018 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.41% | 0.00% | 433,577 | 263,884 | 155.51% | 2,675,170 | Mar 31, 2024 |
| STATE STREET CORP | 1.43% | 0.00% | 1,514,419 | 250,690 | 19.84% | 9,343,965 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.75% | 0.00% | 1,861,254 | 233,891 | 14.37% | 11,485,000 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.16% | 0.02% | 171,926 | 171,926 | 100.00% | 1,060,783 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.16% | 0.00% | 164,620 | 149,920 | 1019.86% | 1,016,000 | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.14% | 0.05% | 144,300 | 144,300 | 100.00% | 890,331 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.71% | 0.00% | 757,291 | 130,841 | 20.89% | 4,672,485 | Mar 31, 2024 |
As of Mar 31 2024, Wave Life Sciences's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 1.12M stocks of WVE, valued at $10.09M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 0.08% | 0.00% | 84,629 | -1,897,623 | -95.73% | 522,161 | Mar 31, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -1,452,778 | -100.00% | - | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.86% | 0.03% | 1,974,737 | -1,238,763 | -38.55% | 12,184,127 | Mar 31, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 2.71% | 0.01% | 2,876,440 | -882,968 | -23.49% | 17,747,635 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.90% | 0.06% | 5,201,389 | -786,341 | -13.13% | 32,092,570 | Mar 31, 2024 |
| MAVERICK CAPITAL LTD | 7.25% | 0.89% | 7,688,079 | -759,725 | -8.99% | 47,435,447 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.89% | 0.05% | 948,444 | -443,117 | -31.84% | 5,851,899 | Mar 31, 2024 |
| BELLEVUE GROUP AG | 3.86% | 0.39% | 4,094,458 | -400,000 | -8.90% | 25,262,806 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.05% | 0.00% | 55,129 | -377,804 | -87.27% | 340,146 | Mar 31, 2024 |
| M28 CAPITAL MANAGEMENT LP | 6.60% | 31.91% | 7,000,000 | -373,413 | -5.06% | 43,190,000 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 5.04% | 2.42% | 5,350,000 | -250,000 | -4.46% | 33,009,500 | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.82% | 0.05% | 871,500 | -200,000 | -18.67% | 5,377,155 | Mar 31, 2024 |
| WS MANAGEMENT LLLP | - | - | - | -192,722 | -100.00% | - | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.30% | 0.00% | 313,405 | -186,804 | -37.35% | 1,933,708 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -103,300 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | 0.09% | 0.00% | 93,794 | -87,473 | -48.26% | 579,000 | Mar 31, 2024 |
| JAMES J. BURNS & COMPANY, LLC | - | - | - | -65,049 | -100.00% | - | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.03% | 0.00% | 27,541 | -61,429 | -69.04% | 169,928 | Mar 31, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.57% | 0.15% | 600,155 | -55,176 | -8.42% | 3,702,956 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.32% | 0.00% | 340,678 | -50,454 | -12.90% | 2,101,983 | Mar 31, 2024 |
As of Mar 31 2024, Wave Life Sciences's biggest institutional seller is CITADEL ADVISORS LLC. The company sold -1.90M shares of WVE, valued at $522.16K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 0.56% | 0.40% | 590,088 | 590,088 | 100.00% | 3,640,843 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.47% | 0.85% | 495,471 | 495,471 | 100.00% | 3,057,056 | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.44% | 0.01% | 462,582 | 462,582 | 100.00% | 2,854,131 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.27% | 0.22% | 286,585 | 286,585 | 100.00% | 1,768,229 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.27% | 0.00% | 285,092 | 285,092 | 100.00% | 1,759,018 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.16% | 0.02% | 171,926 | 171,926 | 100.00% | 1,060,783 | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.14% | 0.05% | 144,300 | 144,300 | 100.00% | 890,331 | Mar 31, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.11% | 0.00% | 113,840 | 113,840 | 100.00% | 702,000 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 0.09% | 0.00% | 97,142 | 97,142 | 100.00% | 599,366 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.09% | 0.05% | 95,037 | 95,037 | 100.00% | 586,000 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.08% | 0.00% | 86,100 | 86,100 | 100.00% | 531,237 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.06% | 0.02% | 65,565 | 65,565 | 100.00% | 404,536 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 0.00% | 58,100 | 58,100 | 100.00% | 358,477 | Mar 31, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.05% | 0.05% | 56,051 | 56,051 | 100.00% | 345,835 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.04% | 0.00% | 42,223 | 42,223 | 100.00% | 260,516 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.03% | 0.04% | 30,000 | 30,000 | 100.00% | 185,100 | Mar 31, 2024 |
| ATOM INVESTORS LP | 0.02% | 0.02% | 20,640 | 20,640 | 100.00% | 127,349 | Mar 31, 2024 |
| MACKENZIE FINANCIAL CORP | 0.01% | 0.00% | 13,982 | 13,982 | 100.00% | 86,269 | Mar 31, 2024 |
| PDT PARTNERS, LLC | 0.01% | 0.01% | 13,300 | 13,300 | 100.00% | 82,061 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.01% | - | 12,800 | 12,800 | 100.00% | 78,976 | Mar 31, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.01% | 0.00% | 11,582 | 11,582 | 100.00% | 71,461 | Mar 31, 2024 |
| 0.01% | 0.00% | 8,971 | 8,971 | 100.00% | 55,349 | Mar 31, 2024 | |
| QUADRANT CAPITAL GROUP LLC | 0.00% | 0.00% | 2,396 | 2,396 | 100.00% | 14,784 | Mar 31, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.00% | 0.00% | 1,100 | 1,100 | 100.00% | 6,787 | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,007 | 1,007 | 100.00% | 6,212 | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.00% | - | 100 | 100 | 100.00% | 562 | Mar 31, 2024 |
| GAMMA INVESTING LLC | 0.00% | 0.00% | 62 | 62 | 100.00% | 383 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 12 | 12 | 100.00% | 74 | Mar 31, 2024 |
Wave Life Sciences's largest new institutional shareholder by number of shares is IKARIAN CAPITAL, LLC, purchased 590.09K shares, valued at $3.64M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MAVEN SECURITIES LTD | - | - | - | -1,452,778 | -100.00% | - | Mar 31, 2024 |
| WS MANAGEMENT LLLP | - | - | - | -192,722 | -100.00% | - | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -103,300 | -100.00% | - | Mar 31, 2024 |
| JAMES J. BURNS & COMPANY, LLC | - | - | - | -65,049 | -100.00% | - | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -36,580 | -100.00% | - | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -35,523 | -100.00% | - | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -34,562 | -100.00% | - | Mar 31, 2024 |
| SEI INVESTMENTS CO | - | - | - | -29,000 | -100.00% | - | Mar 31, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -20,053 | -100.00% | - | Mar 31, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -16,950 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -14,681 | -100.00% | - | Mar 31, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -10,045 | -100.00% | - | Mar 31, 2024 |
| STATE OF WYOMING | - | - | - | -7,244 | -100.00% | - | Mar 31, 2024 |
| FORTITUDE FAMILY OFFICE, LLC | - | - | - | -64 | -100.00% | - | Mar 31, 2024 |
Wave Life Sciences's largest sold out institutional shareholder by shares sold is MAVEN SECURITIES LTD, sold -1.45M shares, valued at -, as of undefined.
Wave Life Sciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| PRIMECAP Odyssey Funds | 0.46% | 3,768,470 | - | - | Jan 31, 2024 |
| Clough Funds Trust | 0.22% | 9,200 | - | - | Jan 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,512 | -5,067 | -77.02% | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,945,386 | 1,034,753 | 113.63% | Dec 31, 2023 |
| VANGUARD HORIZON FUNDS | 0.00% | 48,932 | - | - | Dec 31, 2023 |
| ALGER FUNDS | 0.00% | 2,000 | - | - | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 13,200 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 25,105 | - | - | Dec 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 45,825 | - | - | Dec 31, 2023 |
| Forethought Variable Insurance Trust | 0.00% | 3,600 | - | - | Dec 29, 2023 |
| Meeder Funds | 0.00% | 3,975 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 971 | -19,726 | -95.31% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 909 | - | - | Dec 31, 2023 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 11,271 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 259,236 | 27,909 | 12.06% | Feb 29, 2024 |
| ProFunds | 0.00% | 842 | 345 | 69.42% | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,883 | - | - | Dec 31, 2023 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,587 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 33,770 | - | - | Dec 29, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 9,353 | -80 | -0.85% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 29,537 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 51,548 | 11,156 | 27.62% | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 8,294 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,969 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,097 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,879 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 31,495 | - | - | Dec 31, 2023 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 25,994 | 25,994 | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 25,203 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,328 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 42,611 | 24,611 | 136.73% | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 860 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 20,850 | -410 | -1.93% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 68 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 94 | - | - | Jan 31, 2024 |
Wave Life Sciences's largest mutual fund holder by % of total assets is "PRIMECAP Odyssey Funds", owning 3.77M shares, compromising 0.46% of its total assets.
Wave Life Sciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 133 | 15.65% |
| 31 Dec, 23 | 115 | 35.29% |
| 30 Sep, 23 | 85 | 3.66% |
| 30 Jun, 23 | 82 | 10.81% |
| 31 Mar, 23 | 74 | -2.63% |
| 31 Dec, 22 | 76 | 28.81% |
| 30 Sep, 22 | 59 | 1.72% |
| 30 Jun, 22 | 58 | -26.58% |
| 31 Mar, 22 | 79 | -16.84% |
| 31 Dec, 21 | 95 | 9.20% |
| 30 Sep, 21 | 87 | - |
| 30 Jun, 21 | 87 | -22.32% |
| 31 Mar, 21 | 112 | - |
| 31 Dec, 20 | 112 | - |
| 30 Sep, 20 | 112 | 20.43% |
| 30 Jun, 20 | 93 | 12.05% |
| 31 Mar, 20 | 83 | -23.85% |
| 31 Dec, 19 | 109 | 19.78% |
| 30 Sep, 19 | 91 | -15.74% |
| 30 Jun, 19 | 108 | -5.26% |
| 31 Mar, 19 | 114 | 23.91% |
| 31 Dec, 18 | 92 | - |
| 30 Sep, 18 | 92 | 17.95% |
| 30 Jun, 18 | 78 | -1.27% |
| 31 Mar, 18 | 79 | 9.72% |
| 31 Dec, 17 | 72 | 24.14% |
| 30 Sep, 17 | 58 | 3.57% |
| 30 Jun, 17 | 56 | 12.00% |
| 31 Mar, 17 | 50 | -1.96% |
| 31 Dec, 16 | 51 | 10.87% |
| 30 Sep, 16 | 46 | 21.05% |
| 30 Jun, 16 | 38 | 80.95% |
| 31 Mar, 16 | 21 | 10.53% |
| 31 Dec, 15 | 19 | - |
As of 31 Mar 24, 133 institutions are holding Wave Life Sciences's shares, representing an increase of 15.65% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 91,412,702 | 0.28% |
| 31 Dec, 23 | 91,159,812 | 25.57% |
| 30 Sep, 23 | 72,599,400 | 0.63% |
| 30 Jun, 23 | 72,146,382 | 4.02% |
| 31 Mar, 23 | 69,357,463 | -95.72% |
| 31 Dec, 22 | 1,621,127,223 | 2311.60% |
| 30 Sep, 22 | 67,222,112 | -0.83% |
| 30 Jun, 22 | 67,785,427 | 42.13% |
| 31 Mar, 22 | 47,692,479 | 0.80% |
| 31 Dec, 21 | 47,313,303 | 26.44% |
| 30 Sep, 21 | 37,418,806 | 1.18% |
| 30 Jun, 21 | 36,981,086 | -3.21% |
| 31 Mar, 21 | 38,208,541 | 5.88% |
| 31 Dec, 20 | 36,086,986 | -2.32% |
| 30 Sep, 20 | 36,945,355 | 26.38% |
| 30 Jun, 20 | 29,233,533 | -2.65% |
| 31 Mar, 20 | 30,029,392 | 2.03% |
| 31 Dec, 19 | 29,432,050 | -4.62% |
| 30 Sep, 19 | 30,856,870 | 1.35% |
| 30 Jun, 19 | 30,447,153 | 3.56% |
| 31 Mar, 19 | 29,400,293 | 20.53% |
| 31 Dec, 18 | 24,393,064 | 2.48% |
| 30 Sep, 18 | 23,803,154 | -2.71% |
| 30 Jun, 18 | 24,465,389 | 3.39% |
| 31 Mar, 18 | 23,663,823 | 6.47% |
| 31 Dec, 17 | 22,225,357 | 8.46% |
| 30 Sep, 17 | 20,492,602 | 6.09% |
| 30 Jun, 17 | 19,316,343 | 22.72% |
| 31 Mar, 17 | 15,739,701 | 6.19% |
| 31 Dec, 16 | 14,822,273 | 5.41% |
| 30 Sep, 16 | 14,061,154 | -0.98% |
| 30 Jun, 16 | 14,199,637 | 1.50% |
| 31 Mar, 16 | 13,989,802 | 1.46% |
| 31 Dec, 15 | 13,788,882 | - |
Wave Life Sciences (WVE) has 91.41M shares outstanding as of 31 Mar 24, up 0.28% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 86.16% | 1.17% |
| 31 Dec, 23 | 85.98% | 1.81% |
| 30 Sep, 23 | 68.84% | 1.38% |
| 30 Jun, 23 | 70.69% | 1.53% |
| 31 Mar, 23 | 67.96% | 0.00% |
| 31 Dec, 22 | 1724.72% | 33.65% |
| 30 Sep, 22 | 71.59% | 0.69% |
| 30 Jun, 22 | 101.96% | 1.64% |
| 31 Mar, 22 | 78.81% | 0.95% |
| 31 Dec, 21 | 91.29% | 1.68% |
| 30 Sep, 21 | 73.79% | 1.35% |
| 30 Jun, 21 | 74.00% | 1.22% |
| 31 Mar, 21 | 77.82% | 1.42% |
| 31 Dec, 20 | 73.98% | 0.80% |
| 30 Sep, 20 | 96.30% | 1.40% |
| 30 Jun, 20 | 83.02% | 1.09% |
| 31 Mar, 20 | 87.14% | 1.18% |
| 31 Dec, 19 | 85.80% | 1.06% |
| 30 Sep, 19 | 90.01% | 1.14% |
| 30 Jun, 19 | 88.87% | 1.09% |
| 31 Mar, 19 | 90.19% | 1.27% |
| 31 Dec, 18 | 84.20% | 1.28% |
| 30 Sep, 18 | 81.15% | 1.15% |
| 30 Jun, 18 | 83.95% | 1.17% |
| 31 Mar, 18 | 84.76% | 1.21% |
| 31 Dec, 17 | 83.83% | 1.54% |
| 30 Sep, 17 | 73.82% | 1.43% |
| 30 Jun, 17 | 71.81% | 1.61% |
| 31 Mar, 17 | 66.89% | 1.69% |
| 31 Dec, 16 | 62.99% | 1.75% |
| 30 Sep, 16 | 59.97% | 1.53% |
| 30 Jun, 16 | 62.53% | 1.48% |
| 31 Mar, 16 | 64.91% | 1.59% |
| 31 Dec, 15 | 63.98% | - |
As of 31 Mar 24, Wave Life Sciences is held by 86.16% institutional shareholders, representing a 1.17% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 87 | 1.16% |
| 31 Dec, 23 | 86 | 126.32% |
| 30 Sep, 23 | 38 | -19.15% |
| 30 Jun, 23 | 47 | 23.68% |
| 31 Mar, 23 | 38 | -25.49% |
| 31 Dec, 22 | 51 | 82.14% |
| 30 Sep, 22 | 28 | 21.74% |
| 30 Jun, 22 | 23 | -17.86% |
| 31 Mar, 22 | 28 | -50.88% |
| 31 Dec, 21 | 57 | 42.50% |
| 30 Sep, 21 | 40 | -9.09% |
| 30 Jun, 21 | 44 | -6.38% |
| 31 Mar, 21 | 47 | -18.97% |
| 31 Dec, 20 | 58 | -18.31% |
| 30 Sep, 20 | 71 | 42.00% |
| 30 Jun, 20 | 50 | 16.28% |
| 31 Mar, 20 | 43 | -23.21% |
| 31 Dec, 19 | 56 | 33.33% |
| 30 Sep, 19 | 42 | -39.13% |
| 30 Jun, 19 | 69 | -20.69% |
| 31 Mar, 19 | 87 | 81.25% |
| 31 Dec, 18 | 48 | - |
| 30 Sep, 18 | 48 | -5.88% |
| 30 Jun, 18 | 51 | 6.25% |
| 31 Mar, 18 | 48 | 23.08% |
| 31 Dec, 17 | 39 | 21.88% |
| 30 Sep, 17 | 32 | -23.81% |
| 30 Jun, 17 | 42 | 55.56% |
| 31 Mar, 17 | 27 | -12.90% |
| 31 Dec, 16 | 31 | 14.81% |
| 30 Sep, 16 | 27 | -6.90% |
| 30 Jun, 16 | 29 | 190.00% |
| 31 Mar, 16 | 10 | -47.37% |
| 31 Dec, 15 | 19 | - |
87 institutional shareholders have increased their position in WVE stock as of 31 Mar 24 compared to 86 in the previous quarter (a 1.16% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 32 | 220.00% |
| 31 Dec, 23 | 10 | -64.29% |
| 30 Sep, 23 | 28 | 55.56% |
| 30 Jun, 23 | 18 | -30.77% |
| 31 Mar, 23 | 26 | 62.50% |
| 31 Dec, 22 | 16 | -5.88% |
| 30 Sep, 22 | 17 | -37.04% |
| 30 Jun, 22 | 27 | -18.18% |
| 31 Mar, 22 | 33 | 73.68% |
| 31 Dec, 21 | 19 | -26.92% |
| 30 Sep, 21 | 26 | -3.70% |
| 30 Jun, 21 | 27 | -20.59% |
| 31 Mar, 21 | 34 | 13.33% |
| 31 Dec, 20 | 30 | 3.45% |
| 30 Sep, 20 | 29 | 11.54% |
| 30 Jun, 20 | 26 | 13.04% |
| 31 Mar, 20 | 23 | -25.81% |
| 31 Dec, 19 | 31 | - |
| 30 Sep, 19 | 31 | 63.16% |
| 30 Jun, 19 | 19 | 26.67% |
| 31 Mar, 19 | 15 | -54.55% |
| 31 Dec, 18 | 33 | 22.22% |
| 30 Sep, 18 | 27 | 35.00% |
| 30 Jun, 18 | 20 | -4.76% |
| 31 Mar, 18 | 21 | -16.00% |
| 31 Dec, 17 | 25 | 108.33% |
| 30 Sep, 17 | 12 | 50.00% |
| 30 Jun, 17 | 8 | -38.46% |
| 31 Mar, 17 | 13 | 18.18% |
| 31 Dec, 16 | 11 | 10.00% |
| 30 Sep, 16 | 10 | 100.00% |
| 30 Jun, 16 | 5 | - |
| 31 Mar, 16 | 5 | - |
| 31 Dec, 15 | - | - |
32 institutional shareholders have reduced their position in WVE stock as of 31 Mar 24 compared to 10 in the previous quarter (a 220.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 133 | 15.65% | 91,412,702 | 0.28% | 86.16% | 1.17% | 87 | 1.16% | 32 | 220.00% |
| 31 Dec, 23 | 115 | 35.29% | 91,159,812 | 25.57% | 85.98% | 1.81% | 86 | 126.32% | 10 | -64.29% |
| 30 Sep, 23 | 85 | 3.66% | 72,599,400 | 0.63% | 68.84% | 1.38% | 38 | -19.15% | 28 | 55.56% |
| 30 Jun, 23 | 82 | 10.81% | 72,146,382 | 4.02% | 70.69% | 1.53% | 47 | 23.68% | 18 | -30.77% |
| 31 Mar, 23 | 74 | -2.63% | 69,357,463 | -95.72% | 67.96% | 0.00% | 38 | -25.49% | 26 | 62.50% |
| 31 Dec, 22 | 76 | 28.81% | 1,621,127,223 | 2311.60% | 1724.72% | 33.65% | 51 | 82.14% | 16 | -5.88% |
| 30 Sep, 22 | 59 | 1.72% | 67,222,112 | -0.83% | 71.59% | 0.69% | 28 | 21.74% | 17 | -37.04% |
| 30 Jun, 22 | 58 | -26.58% | 67,785,427 | 42.13% | 101.96% | 1.64% | 23 | -17.86% | 27 | -18.18% |
| 31 Mar, 22 | 79 | -16.84% | 47,692,479 | 0.80% | 78.81% | 0.95% | 28 | -50.88% | 33 | 73.68% |
| 31 Dec, 21 | 95 | 9.20% | 47,313,303 | 26.44% | 91.29% | 1.68% | 57 | 42.50% | 19 | -26.92% |
| 30 Sep, 21 | 87 | - | 37,418,806 | 1.18% | 73.79% | 1.35% | 40 | -9.09% | 26 | -3.70% |
| 30 Jun, 21 | 87 | -22.32% | 36,981,086 | -3.21% | 74.00% | 1.22% | 44 | -6.38% | 27 | -20.59% |
| 31 Mar, 21 | 112 | - | 38,208,541 | 5.88% | 77.82% | 1.42% | 47 | -18.97% | 34 | 13.33% |
| 31 Dec, 20 | 112 | - | 36,086,986 | -2.32% | 73.98% | 0.80% | 58 | -18.31% | 30 | 3.45% |
| 30 Sep, 20 | 112 | 20.43% | 36,945,355 | 26.38% | 96.30% | 1.40% | 71 | 42.00% | 29 | 11.54% |
| 30 Jun, 20 | 93 | 12.05% | 29,233,533 | -2.65% | 83.02% | 1.09% | 50 | 16.28% | 26 | 13.04% |
| 31 Mar, 20 | 83 | -23.85% | 30,029,392 | 2.03% | 87.14% | 1.18% | 43 | -23.21% | 23 | -25.81% |
| 31 Dec, 19 | 109 | 19.78% | 29,432,050 | -4.62% | 85.80% | 1.06% | 56 | 33.33% | 31 | - |
| 30 Sep, 19 | 91 | -15.74% | 30,856,870 | 1.35% | 90.01% | 1.14% | 42 | -39.13% | 31 | 63.16% |
| 30 Jun, 19 | 108 | -5.26% | 30,447,153 | 3.56% | 88.87% | 1.09% | 69 | -20.69% | 19 | 26.67% |
| 31 Mar, 19 | 114 | 23.91% | 29,400,293 | 20.53% | 90.19% | 1.27% | 87 | 81.25% | 15 | -54.55% |
| 31 Dec, 18 | 92 | - | 24,393,064 | 2.48% | 84.20% | 1.28% | 48 | - | 33 | 22.22% |
| 30 Sep, 18 | 92 | 17.95% | 23,803,154 | -2.71% | 81.15% | 1.15% | 48 | -5.88% | 27 | 35.00% |
| 30 Jun, 18 | 78 | -1.27% | 24,465,389 | 3.39% | 83.95% | 1.17% | 51 | 6.25% | 20 | -4.76% |
| 31 Mar, 18 | 79 | 9.72% | 23,663,823 | 6.47% | 84.76% | 1.21% | 48 | 23.08% | 21 | -16.00% |
| 31 Dec, 17 | 72 | 24.14% | 22,225,357 | 8.46% | 83.83% | 1.54% | 39 | 21.88% | 25 | 108.33% |
| 30 Sep, 17 | 58 | 3.57% | 20,492,602 | 6.09% | 73.82% | 1.43% | 32 | -23.81% | 12 | 50.00% |
| 30 Jun, 17 | 56 | 12.00% | 19,316,343 | 22.72% | 71.81% | 1.61% | 42 | 55.56% | 8 | -38.46% |
| 31 Mar, 17 | 50 | -1.96% | 15,739,701 | 6.19% | 66.89% | 1.69% | 27 | -12.90% | 13 | 18.18% |
| 31 Dec, 16 | 51 | 10.87% | 14,822,273 | 5.41% | 62.99% | 1.75% | 31 | 14.81% | 11 | 10.00% |
| 30 Sep, 16 | 46 | 21.05% | 14,061,154 | -0.98% | 59.97% | 1.53% | 27 | -6.90% | 10 | 100.00% |
| 30 Jun, 16 | 38 | 80.95% | 14,199,637 | 1.50% | 62.53% | 1.48% | 29 | 190.00% | 5 | - |
| 31 Mar, 16 | 21 | 10.53% | 13,989,802 | 1.46% | 64.91% | 1.59% | 10 | -47.37% | 5 | - |
| 31 Dec, 15 | 19 | - | 13,788,882 | - | 63.98% | - | 19 | - | - | - |
Wave Life Sciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Wave Life Sciences's stock was made by Moran Kyle on Apr 05 2024, selling 15,630 shares at $6.17 per share (valued at $96.42K). The last insider buy of WVE was made by GSK plc on Jan 30 2024, buying 3,300,000 shares at $5.00 per share (worth $16.50M).
Wave Life Sciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | 4 | - | - |
| Q4 2023 | 3 | - | - |
| Q3 2023 | 8 | 1 | 800.00% |
| Q1 2023 | 4 | 4 | 100.00% |
| Q4 2022 | 1 | - | - |
| Q3 2022 | 23 | - | - |
| Q2 2022 | 8 | 5 | 160.00% |
| Q1 2022 | 5 | 5 | 100.00% |
| Q3 2021 | 8 | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 11 | 6 | 183.33% |
| Q4 2020 | - | 5 | - |
| Q3 2020 | 12 | 9 | 133.33% |
| Q1 2020 | 5 | 7 | 71.43% |
| Q4 2019 | 1 | 5 | 20.00% |
| Q3 2019 | 12 | 2 | 600.00% |
| Q1 2019 | 7 | 12 | 58.33% |
| Q4 2018 | - | 2 | - |
| Q3 2018 | 12 | 10 | 120.00% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Wave Life Sciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 3 | - | - |
| Q3 2023 | - | 1 | - |
| Q1 2023 | - | 4 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 3 | 5 | 60.00% |
| Q1 2022 | - | 5 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 5 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | 6 | - |
| Q1 2020 | - | 5 | - |
| Q4 2019 | - | 4 | - |
| Q3 2019 | - | 2 | - |
| Q1 2019 | 1 | 11 | 9.09% |
| Q4 2018 | - | 2 | - |
| Q3 2018 | - | 5 | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Wave Life Sciences's stocks.
Wave Life Sciences Peer Ownership
| Ticker | Company |
|---|---|
| TERN | Terns Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| TCRX | TScan Therapeutics, Inc. |
| VECT | VectivBio Holding AG |
| XFOR | X4 Pharmaceuticals, Inc. |
| ITOS | iTeos Therapeutics, Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| PRQR | ProQR Therapeutics N.V. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| ARWR | Arrowhead Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| CTMX | CytomX Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| NLTX | Neurogene Inc. |
| ASMB | Assembly Biosciences, Inc. |
WVE Ownership FAQ
Who Owns Wave Life Sciences?
Wave Life Sciences is owned by institutional shareholders (86.16%), insiders (16.53%), and public (-2.69%). The largest institutional shareholder of Wave Life Sciences is RA CAPITAL MANAGEMENT, L.P. (17.16% of total shares) and the top mutual fund owner is PRIMECAP Odyssey Funds (0.46% of total shares).
Who are the major institutional shareholders of Wave Life Sciences?
Wave Life Sciences's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., MAVERICK CAPITAL LTD, M28 CAPITAL MANAGEMENT LP, BLACKROCK INC., and 683 CAPITAL MANAGEMENT, LLC. The top five shareholders own together 42.05% of the company's share outstanding.
How many Wave Life Sciences shareholders are there?
As of Mar 2024, there are 133 institutional shareholders of Wave Life Sciences.
What percentage of Wave Life Sciences is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 18.2M shares of Wave Life Sciences, representing 17.16% of the company's total shares outstanding, valued at $112.31M (as of Mar 2024).
What percentage of Wave Life Sciences is owned by MAVERICK CAPITAL LTD?
As of Mar 2024, MAVERICK CAPITAL LTD holds 7.69M shares of Wave Life Sciences (WVE), compromising 7.25% of the company, valued at $47.44M.
What percentage of Wave Life Sciences is owned by M28 CAPITAL MANAGEMENT LP?
M28 CAPITAL MANAGEMENT LP is the third largest holder of Wave Life Sciences. The company owns 7M of the company's shares outstanding (worth $43.19M).